DecisionView Appoints Life Sciences Software Expert, Gonzalo Castro, to Vice President of Product Marketing

SAN FRANCISCO, Jan. 29 /PRNewswire/ -- DecisionView, Inc., the leading provider of software solutions designed to improve time to market and reduce clinical trial costs for life sciences companies, today announced the appointment of Gonzalo Castro as Vice President, Product Marketing and a member of the company's management team.

With over 10 years of industry experience, Mr. Castro is a seasoned product marketing leader who has an impressive track record in developing and commercializing successful and market leading software products for the Life Sciences industry. "We are delighted to welcome Gonzalo to the DecisionView management team," said Steve Andrade, CEO of DecisionView. "His expertise in the Life Sciences industry, coupled with his software application development and product marketing experience, makes him a strategic addition to our growing company."

Mr. Castro joins DecisionView from Oracle Corporation, where he was Director of Life Sciences Product Strategy. Prior to Oracle, he worked at Siebel Systems in a number of roles within the Life Sciences Product Marketing group, successfully conceiving, developing, and launching applications that are used by some of the largest global pharmaceutical companies. In addition to his software career, Mr. Castro served as an Operations Research Consultant at ZS Associates where he applied advanced modeling and optimization algorithms to enhance sales and marketing strategies, generating new revenue streams for the company. Mr. Castro holds an MS in Industrial Engineering from Purdue University and an MBA from the Wharton School of Business.

"DecisionView is an exciting software company that is focused on solving significant clinical trial performance challenges using innovative analytical and predictive modeling approaches," said Gonzalo Castro. "The market is ready for an application solution that improves the speed of clinical trials by optimizing the clinical trial enrollment process. The recent enhancements to StudyOptimizer 3.5.3, released this week, are a proof point to the company's ongoing commitment to develop innovative solutions that deliver business value to the life sciences industry," Castro continued.

About DecisionView

DecisionView develops innovative web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. DecisionView helps organizations make informed decisions by aggregating data from multiple sources and providing analytics, simulations and scenario modeling that deliver proven business value by reducing clinical trial costs and improving clinical trial predictability. Granite Ventures, Partech International and first Ventury are primary investors in the company.

Additional information about DecisionView can be found at http://www.decisionview.com/.